A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

NCT01395121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Mucosal Lentiginous Melanoma
Acral Lentiginous Malignant Melanoma

Interventions

DRUG: nilotinib

Sponsor

Institute of Cancer Research, United Kingdom

Collaborators

[object Object]